clopidogrel and benzofurans

clopidogrel has been researched along with benzofurans in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Jilma, B; Krumphuber, J; Siller-Matula, JM1
Ding, J; Ding, Z; Kunapuli, SP; Li, J; Liu, L; Luo, X; Wen, Z; Ye, J; Zhang, S; Zhang, Y1
Lv, J; Xie, Z; Zhao, D; Zhao, G1

Reviews

1 review(s) available for clopidogrel and benzofurans

ArticleYear
Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases.
    British journal of pharmacology, 2010, Feb-01, Volume: 159, Issue:3

    Topics: Adenosine; Adenosine Monophosphate; Benzofurans; Blood Platelets; Carbamates; Clinical Trials as Topic; Clopidogrel; Humans; Lactones; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyridines; Receptor, PAR-1; Receptors, Proteinase-Activated; Thiophenes; Ticagrelor; Ticlopidine; von Willebrand Factor

2010

Trials

1 trial(s) available for clopidogrel and benzofurans

ArticleYear
Efficacy and safety of butylphthalide in secondary prevention of stroke: study protocol for a multicenter, real world trial based on Internet.
    BMC neurology, 2022, Aug-19, Volume: 22, Issue:1

    Topics: Aspirin; Benzofurans; Clopidogrel; Double-Blind Method; Humans; Internet; Ischemic Stroke; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Secondary Prevention; Treatment Outcome

2022

Other Studies

1 other study(ies) available for clopidogrel and benzofurans

ArticleYear
Salvianolic acid B inhibits platelets as a P2Y12 antagonist and PDE inhibitor: evidence from clinic to laboratory.
    Thrombosis research, 2014, Volume: 134, Issue:4

    Topics: Acute Coronary Syndrome; Aged; Aspirin; Benzofurans; Blood Platelets; Clopidogrel; Drugs, Chinese Herbal; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Platelet Activation; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Salvia miltiorrhiza; Ticlopidine

2014